SPC428
Mítapívat eða lyfjafræðilega viðunandi salt þar af, sérstaklega mítapívatsúlfat
Status:
VeittApplication date:
28.4.2023Application published:
15.7.2023Grant published:
15.10.2024
Max expiry date:
28.6.2035Medicine name:
PyrukyndMedicine for children:
No
Timeline
Today
28.4.2023Application
15.7.2023Publication
15.10.2024Registration
28.6.2035Expires
Marketing license
IS authorization number:
EU/1/22/1662/001-003; EU/1/22/1662/004-005; EU/1/22/1662/006Date:
1.12.2022
Foreign authorization number:
EU/1/22/1662Date:
9.11.2022
Owner
Name:
Agios Pharmaceuticals, Inc.Address:
88 Sidney Street, Cambridge US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2448582
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 16.09.2024